|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short term deposit | ||||||||||||||||||||
| Sort term deposit | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Account receivables | ||||||||||||||||||||
| Other receivables and prepaid expenses | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long term deposits | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating right-of-use asset | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Investment in JV | ||||||||||||||||||||
| Investment in marketable securities | ||||||||||||||||||||
| Other non-current asset | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Bank overdraft | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Short-term loans | ||||||||||||||||||||
| Trade payables | ||||||||||||||||||||
| Liabilities to related parties | ||||||||||||||||||||
| Seller payables | ||||||||||||||||||||
| Other payables | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term loans | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Other Non-Current Liabilities | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock of $0.001 par value - Authorized: 250,000,000 shares; Issued and outstanding: 602,271 and 579,973 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
